What are the Historical Developments and Current Growth Metrics of the Cardiovascular Catheters Market?
The cardiovascular catheters market has seen considerable growth due to a variety of factors.
• In recent years, there has been robust growth in the market size of cardiovascular catheters. It is predicted to expand from $20.05 billion in 2024 to $21.87 billion in 2025, noting a compound annual growth rate (CAGR) of 9.0%.
This solid growth during the historic period is due to factors such as increased funding for R&D, a rise in catheter utilization in EP procedures, the broadening of cardiac catheterization labs in medical centers, an upsurge in interventional cardiology procedures, and an escalating prevalence of diabetes.
What Is The Projected Growth Of The Cardiovascular Catheters Template Market?
The cardiovascular catheters market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the cardiovascular catheters market is anticipated to experience robust growth, reaching $30.61 billion by 2029 with a compound annual growth rate (CAGR) of 8.8%.
Factors contributing to this projected growth during the forecast period include an emphasis on cutting healthcare fees, implementation of hybrid operating rooms, escalated investment in cardiovascular research by public and private sectors, heightened use of drug-eluting catheters and the creation and application of biodegradable catheter materials. The forecast period is also expected to see significant trends such as incorporation of artificial intelligence in catheter-related processes, advancements in imaging technologies, production of miniaturized catheters, utilization of robotic-assisted catheter procedures, and invention of wireless, battery-free catheters.
What Are The Key Drivers Fueling Growth In The Cardiovascular Catheters Market?
The rise in vascular heart diseases is anticipated to drive the growth of the cardiovascular catheter market. Vascular heart diseases are a group of conditions impacting the blood vessels that supply the heart or are located within the heart. Lifestyle changes like diet and physical activity, along with an aging population, and increasing instances of conditions such as diabetes and hypertension contribute to the onset of vascular heart diseases. Cardiovascular catheters serve patients suffering from these conditions by facilitating minimally invasive procedures to diagnose, treat, and manage conditions like blocked arteries and abnormal heart rhythms, resulting in enhanced recovery and improved health outcomes. For example, the American Heart Association, a nonprofit organization based in the US, reported in January 2024, that the death toll from cardiovascular diseases stood at 931,578, up from 928,741 in 2023. Furthermore, the age-adjusted mortality rate due to cardiovascular disease also witnessed a slight increase, reaching 233.3 per 100,000, recording a 4.0% rise from the rate of 224.4 per 100,000 in the previous year. Hence, the rising incidence of vascular heart diseases is contributing to the growth of the cardiovascular catheters market.
What Are The Principal Market Segments In The Global Cardiovascular Catheters Industry?
The cardiovascular cathetersmarket covered in this report is segmented –
1) By Product: Cardiovascular Therapeutic Catheters, Cardiovascular Diagnostic Catheters
2) By Application: Coronary Artery Diseases (CAD), Cardiac Arrhythmia, Heart Failure, Other Applications
3) By End User: Hospitals, Clinics, Ambulatory Surgical Centers
Subsegments:
1) By Cardiovascular Therapeutic Catheters: Angioplasty Balloons, Stent Delivery Catheters, Catheters for Ablation Therapy, Intracardiac Catheters, Thrombectomy Catheters
2) By Cardiovascular Diagnostic Catheters: Coronary Angiography Catheters, Pressure Monitoring Catheters, Electrophysiology Catheters, Intravenous Catheters for Diagnostic Imaging
Pre-Book The Cardiovascular Catheters Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are New Trends Impacting The Size Of The Cardiovascular Catheters Market?
Leading firms operating in the domain of cardiovascular catheters are inventing state-of-the-art products using cutting-edge technologies, one being the TRUEref technology. This technology amplifies the precision and reliability of cardiac mapping by supplying accurate reference signals, thus improving the identification of arrhythmia and facilitating efficient, targeted treatments. For Example, Biosense Webster Inc., an American company which is part of Johnson & Johnson MedTech, unveiled in July 2023 their OPTRELL mapping catheter. This advanced diagnostic catheter incorporates TRUEref technology and is powered by the CARTO 3 System. With 48 mini electrodes, it provides high-resolution electrophysiological mapping, equipping health professionals with the tools to accurately map complex cardiac arrhythmias and formulate more effective ablation strategies.
Who Are the Key Players In The Cardiovascular Catheters Market?
Major companies operating in the cardiovascular catheters market are:
• Abbott Laboratories
• Medtronic plc
• Johnson & Johnson MedTech
• Koninklijke Philips N.V.
• Stryker Corporation
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Terumo Corporation
• Edwards Lifesciences Corporation
• W. L. Gore & Associates Inc.
• ZOLL Medical Corporation
• Nipro Corporation
• Cook Group Incorporated
• Biotronik SE & Co. KG
• Merit Medical Systems Inc.
• LivaNova plc
• Cordis Corporation
• Asahi Intecc Co. Ltd.
• AngioDynamics Inc.
• Endologix Inc.
• Wellinq
• Cardionovum GmbH
• Avinger Inc.
• CathRx
• Andocor NV
What Are The Regional Insights Into The Cardiovascular Catheters Market?
Asia-Pacific was the largest region in the cardiovascular catheters market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiovascular catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
